Management of antidepressantinduced sexual dysfunction

Australasian Psychiatry

Volumn 22, Issue 6, 2014, Pages 525-528

  Keks, Nicholas A ^a,b   Hope, Judy ^a,b   Culhane, Christine ^c  

^a MONASH UNIVERSITY   (Australia)

^b Delmont Private Hospital   (Australia)

^c FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

Author keywords

Antidepressants; Anxiety; Clinical management; Depression; Sexual dysfunction

Indexed keywords

AGOMELATINE; AMFEBUTAMONE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CITALOPRAM; CLOMIPRAMINE; DESVENLAFAXINE; DOSULEPIN; DOXEPIN; DULOXETINE; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; MIRTAZAPINE; MOCLOBEMIDE; MONOAMINE OXIDASE INHIBITOR; NORTRIPTYLINE; PAROXETINE; PHENELZINE; PLACEBO; REBOXETINE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRANYLCYPROMINE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ANTIDEPRESSANT INDUCED SEXUAL DYSFUNCTION; ARTICLE; CLINICAL TRIAL (TOPIC); HUMAN; MAJOR DEPRESSION; META ANALYSIS (TOPIC); SEXUAL DYSFUNCTION; CHEMICALLY INDUCED; DISEASE MANAGEMENT; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL;

ANTIDEPRESSIVE AGENTS; DISEASE MANAGEMENT; HUMANS; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL;

EID: 84927628572     PISSN: 10398562     EISSN: 14401665     Source Type: Journal    
DOI: 10.1177/1039856214556323     Document Type: Article

References (14)

1. Clayton AH, Croft HA and Handiwala L. Antidepressants and sexual dysfunction: mechanisms and clinical implications. Postgrad Med 2014; 126: 91-99.
2. Taylor MJ. Strategies for managing antidepressant-induced sexual dysfunction: a review. Curr Psychiatr Rep 2006; 8: 431-436.
3. Montejo AL, Llorca G, Izquierdo JA, et al. Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicentre study of 1022 outpatients. Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction. J Clin Psychiatry 2001; 62 (Suppl. 3): 10-21.
4. Clayton AH, Pradko JF, Croft HA, et al. Prevalence of sexual dysfunction among newer antidepressants. J Clin Psychiatry 2002; 63: 357-366.
5. Coleman CC, Cunningham LA, Foster VJ, et al. Sexual dysfunction associated with the treatment of depression: a placebo-controlled comparison of bupropion sustained release and sertraline treatment. Ann Clin Psychiatry 1999; 11: 205-215.
6. Clayton AH, Croft HA, Horrigan JP, et al. Bupropion extended release compared with escitalopram: effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studies. J Clin Psychiatry 2006; 67: 736-746.
7. Clayton AH, Zajecka J, Ferguson JM, et al. Lack of sexual dysfunction with the selective noradrenaline reuptake inhibitor reboxetine during treatment for major depressive disorder. Int Clin Psychopharmacol 2003; 18: 151-156.
8. Delgado PL, Brannan SK, Mallinckrodt CH, et al. Sexual functioning assessed in 4 double-blind placebo-and paroxetine-controlled trials of duloxetine for major depressive disorder. J Clin Psychiatry 2005; 66: 686-692.
9. Kennedy SH and Rizvi S. Sexual dysfunction, depression, and the impact of antidepressants. J Clin Psychopharmacol 2009; 29: 157-164.
10. La Torre A, Giupponi G, Duffy D, et al. Sexual dysfunction related to psychotropic drugs: a critical review -Part I: antidepressants. Pharmacopsychiatry 2013; 46: 191-199.
11. Serreti A and Chiesa A. Treatment-emergent sexual dysfunction related to antidepressants. A meta-analysis. J Clin Psychopharmacol 2009; 29: 259-266.
12. McGahuey CA, Gelenberg AJ, Laukes CA, et al. The Arizona Sexual Experience Scale (ASEX): Reliability and validity. J Sex Marital Ther 2000; 26: 25-40.
13. Baldwin DS and Foong T. Antidepressant drugs and sexual dysfunction. Br J Psychiatry 2013; 202: 396-397.
14. Nurnberg HG, Hensley PL, Heiman JR, et al. Sildenafil treatment of women with antidepressant-associated sexual dysfunction. JAMA 2008; 300: 395-404.